Coherus BioSciences
CHRS
#10125
Rank
โ‚น5.91 B
Marketcap
โ‚น38.30
Share price
-14.34%
Change (1 day)
-64.26%
Change (1 year)

Earnings for Coherus BioSciences (CHRS)

Earnings in 2026 (TTM): -โ‚น13.91 Billion

According to Coherus BioSciences 's latest financial reports the company's current earnings are โ‚น50.93 Million. In 2025 the company made an earning of -โ‚น16.28 Billion, an increase over its 2024 earnings that were of -โ‚น19.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Coherus BioSciences from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น13.91 Billion-14.57%
2025 -โ‚น16.28 Billion-15.4%
2024 -โ‚น19.24 Billion4.1%
2023 -โ‚น18.48 Billion-23.74%
2022 -โ‚น24.23 Billion-1.84%
2021 -โ‚น24.69 Billion-268.38%
2020 โ‚น14.65 B42.13%
2019 โ‚น10.31 B-155.26%
2018 -โ‚น18.67 Billion-12.68%
2017 -โ‚น21.38 Billion90.92%
2016 -โ‚น11.2 Billion-46.49%
2015 -โ‚น20.93 Billion168.87%
2014 -โ‚น7.79 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
โ‚น1.032 T-7,368.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น2.86 B-120.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-โ‚น25.4 Billion 78.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-โ‚น58.58 Billion 312.28%๐Ÿ‡บ๐Ÿ‡ธ USA